Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. SWOT Analysis-Coronary Artery Disease Market

5.1 Strength
5.2 Weakness
5.3 Opportunity
5.4 Threat


6. Porter’s Five Forces

6.1 Bargaining Power of Buyers
6.2 Bargaining Power of Suppliers
6.3 Degree of Competition
6.4 Threat of New Entrants
6.5 Threat of Substitutes


7. Disease Background and Overview

7.1 Introduction
7.2 Etiology and Types
7.3 Cancer Pain Classification Systems

7.3.1 International Association for the Study of Pain (IASP) Taxonomy
7.3.2 ICD-11
7.3.3 Edmonton Classification System for Cancer Pain (ECS-CP)

7.4 Cancer Pain Pathophysiology
7.5 Cancer Pain Syndromes
7.6 Clinical Presentation and Assessment of Pain


8. Treatment and Management

8.1 NCCN Guidelines
8.2 ESMO Clinical Practice Guidelines (2018)
8.3 Spanish Guidelines
8.4 Canadian Recommendations for the Management of Breakthrough Cancer Pain (BTCP)
8.5 Multimodal Personalized Management of Cancer Pain


9. Cancer Pain Management Market – 10 Major Markets


10. Cancer Pain Epidemiology and Patient Population

10.1 Cancer Patients - 10 MM
10.2 Cancer Patients by Type, 2020 - 10 MM
10.3 Cancer Patients by Gender - 10 MM
10.4 Cancer Patients by Mortality Rate – 10 MM


11. Market Share Analysis - Global Cancer Pain Management

11.1 By Treatment
11.2 By Drug Type
11.3 By Disease Indication
11.4 By Country


12. Treatment - Global Cancer Pain Management 10MM

12.1 Immunotherapy
12.2 Radiotherapy
12.3 Chemotherapy
12.4 Hormone Therapy
12.5 Targeted Therapies
12.6 Inhibitors
12.7 Surgery
12.8 Others


13. Drug Type – Global Cancer Pain Management 10 MM

13.1 Opioids
13.2 Non-Opioids
13.3 Nerve Blockers


14. Disease Indication – Global Cancer Pain Management 10 MM

14.1 Lung Cancer
14.2 Colorectal Cancer
14.3 Breast Cancer
14.4 Prostate Cancer
14.5 Blood Cancer
14.6 Others


15. Country – Global Cancer Pain Management 10 MM

15.1 United States

15.1.1 By Cancer Incidence - Per Lakh of Total Population
15.1.2 By Gender - Cancer Patients

15.1.2.1 Male
15.1.2.2 Female

15.1.3 By Type – Cancer Patients, 2020
15.1.4 By Mortality - Cancer Patients
15.1.5 By Price Analysis – Cancer Pain Management Drug Price Per Capita
15.1.6 Market Analysis

15.2 United Kingdom

15.2.1 By Cancer Incidence - Per Lakh of Total Population
15.2.2 By Gender - Cancer Patients

15.2.2.1 Male
15.2.2.2 Female

15.2.3 By Type – Cancer Patients, 2020
15.2.4 By Mortality - Cancer Patients
15.2.5 By Price Analysis – Cancer Pain Management Drug Price Per Capita
15.2.6 Market Analysis

15.3 Japan

15.3.1 By Cancer Incidence - Per Lakh of Total Population
15.3.2 By Gender - Cancer Patients

15.3.2.1 Male
15.3.2.2 Female

15.3.3 By Type – Cancer Patients, 2020
15.3.4 By Mortality - Cancer Patients
15.3.5 By Price Analysis – Cancer Pain Management Drug Price Per Capita
15.3.6 Market Analysis

15.4 France

15.4.1 By Cancer Incidence - Per Lakh of Total Population
15.4.2 By Gender - Cancer Patients

15.4.2.1 Male
15.4.2.2 Female

15.4.3 By Type – Cancer Patients, 2020
15.4.4 By Mortality - Cancer Patients
15.4.5 By Price Analysis – Cancer Pain Management Drug Price Per Capita
15.4.6 Market Analysis

15.5 Germany

15.5.1 By Cancer Incidence - Per Lakh of Total Population
15.5.2 By Gender - Cancer Patients

15.5.2.1 Male
15.5.2.2 Female

15.5.3 By Type – Cancer Patients, 2020
15.5.4 By Mortality - Cancer Patients
15.5.5 By Price Analysis – Cancer Pain Management Drug Price Per Capita
15.5.6 Market Analysis

15.6 Italy

15.6.1 By Cancer Incidence - Per Lakh of Total Population
15.6.2 By Gender - Cancer Patients

15.6.2.1 Male
15.6.2.2 Female

15.6.3 By Type – Cancer Patients, 2020
15.6.4 By Mortality - Cancer Patients
15.6.5 By Price Analysis – Cancer Pain Management Drug Price Per Capita
15.6.6 Market Analysis

15.7 Spain

15.7.1 By Cancer Incidence - Per Lakh of Total Population
15.7.2 By Gender - Cancer Patients

15.7.2.1 Male
15.7.2.2 Female

15.7.3 By Type – Cancer Patients, 2020
15.7.4 By Mortality - Cancer Patients
15.7.5 By Price Analysis – Cancer Pain Management Drug Price Per Capita
15.7.6 Market Analysis

15.8 Saudi Arabia

15.8.1 By Cancer Incidence - Per Lakh of Total Population
15.8.2 By Gender - Cancer Patients

15.8.2.1 Male
15.8.2.2 Female

15.8.3 By Type – Cancer Patients, 2020
15.8.4 By Mortality - Cancer Patients
15.8.5 By Price Analysis – Cancer Pain Management Drug Price Per Capita
15.8.6 Market Analysis

15.9 China

15.9.1 By Cancer Incidence - Per Lakh of Total Population
15.9.2 By Gender - Cancer Patients

15.9.2.1 Male
15.9.2.2 Female

15.9.3 By Type – Cancer Patients, 2020
15.9.4 By Mortality - Cancer Patients
15.9.5 By Price Analysis – Cancer Pain Management Drug Price Per Capita
15.9.6 Market Analysis

15.10 Korea

15.10.1 By Cancer Incidence - Per Lakh of Total Population
15.10.2 By Gender - Cancer Patients

15.10.2.1 Male
15.10.2.2 Female

15.10.3 By Type – Cancer Patients, 2020
15.10.4 By Mortality - Cancer Patients
15.10.5 By Price Analysis – Cancer Pain Management Drug Price Per Capita
15.10.6 Market Analysis

16. Emerging Therapies

16.1 Key Cross Competition
16.2 Tetrodotoxin: WexPharma

16.2.1 Product description
16.2.2 Other developmental activities
16.2.3 Clinical development
16.2.4 Safety and efficacy

16.3 Resiniferatoxin: Sorrento Therapeutics

16.3.1 Product description
16.3.2 Other developmental activities
16.3.3 Clinical development
16.3.4 Safety and efficacy

16.4 QIXLEEF: Tetra Bio-Pharma

16.4.1 Product description
16.4.2 Other developmental activities
16.4.3 Clinical development
16.4.4 Safety and efficacy

17. Company Analysis

17.1 Daiichi Sankyo Co., Ltd.

17.1.1 Overview
17.1.2 Business Strategy
17.1.3 Financial Insight

17.2 Hisamitsu Pharmaceutical Co., Inc.

17.2.1 Overview
17.2.2 Business Strategy
17.2.3 Financial Insight

17.3 Orexo AB

17.3.1 Overview
17.3.2 Business Strategy
17.3.3 Financial Insight

17.4 Pfizer Inc

17.4.1 Overview
17.4.2 Business Strategy
17.4.3 Financial Insight

17.5 Teva Pharmaceutical Industries Limited

17.5.1 Overview
17.5.2 Business Strategy
17.5.3 Financial Insight

17.6 Sanofi

17.6.1 Overview
17.6.2 Business Strategy
17.6.3 Financial Insight

17.7 Johnson & Johnson

17.7.1 Overview
17.7.2 Business Strategy
17.7.3 Financial Insight

17.8 Eli Lilly

17.8.1 Overview
17.8.2 Business Strategy
17.8.3 Financial Insight



List of Figures

Figure-01: Global – Cancer Pain Management Market (Billion US$), 2018 – 2022
Figure-02: Global – Forecast for Cancer Pain Management Market (Billion US$), 2023 – 2030
Figure-03: Treatment – Immunotherapy Market (Million US$), 2018 – 2022
Figure-04: Treatment – Forecast for Immunotherapy Market (Million US$), 2023 – 2030
Figure-05: Treatment – Radiotherapy Market (Million US$), 2018 – 2022
Figure-06: Treatment – Forecast for Radiotherapy Market (Million US$), 2023 – 2030
Figure-07: Treatment – Chemotherapy Market (Million US$), 2018 – 2022
Figure-08: Treatment – Forecast for Chemotherapy Market (Million US$), 2023 – 2030
Figure-09: Treatment – Hormone Therapy Market (Million US$), 2018 – 2022
Figure-10: Treatment – Forecast for Hormone Therapy Market (Million US$), 2023 – 2030
Figure-11: Treatment – Targeted Therapies Market (Million US$), 2018 – 2022
Figure-12: Treatment – Forecast for Targeted Therapies Market (Million US$), 2023 – 2030
Figure-13: Treatment – Inhibitors Market (Million US$), 2018 – 2022
Figure-14: Treatment – Forecast for Inhibitors Market (Million US$), 2023 – 2030
Figure-15: Treatment – Surgery Market (Million US$), 2018 – 2022
Figure-16: Treatment – Forecast for Surgery Market (Million US$), 2023 – 2030
Figure-17: Treatment – Others Market (Million US$), 2018 – 2022
Figure-18: Treatment – Forecast for Others Market (Million US$), 2023 – 2030
Figure-19: Drug Type – Opioids Market (Million US$), 2018 – 2022
Figure-20: Drug Type – Forecast for Opioids Market (Million US$), 2023 – 2030
Figure-21: Drug Type – Non-Opioids Market (Million US$), 2018 – 2022
Figure-22: Drug Type – Forecast for Non-Opioids Market (Million US$), 2023 – 2030
Figure-23: Drug Type – Nerve Blockers Market (Million US$), 2018 – 2022
Figure-24: Drug Type – Forecast for Nerve Blockers Market (Million US$), 2023 – 2030
Figure-25: Disease Indication – Lung Cancer Market (Million US$), 2018 – 2022
Figure-26: Disease Indication – Forecast for Lung Cancer Market (Million US$), 2023 – 2030
Figure-27: Disease Indication – Colorectal Cancer Market (Million US$), 2018 – 2022
Figure-28: Disease Indication – Forecast for Colorectal Cancer Market (Million US$), 2023 – 2030
Figure-29: Disease Indication – Breast Cancer Market (Million US$), 2018 – 2022
Figure-30: Disease Indication – Forecast for Breast Cancer Market (Million US$), 2023 – 2030
Figure-31: Disease Indication – Prostate Cancer Market (Million US$), 2018 – 2022
Figure-32: Disease Indication – Forecast for Prostate Cancer Market (Million US$), 2023 – 2030
Figure-33: Disease Indication – Blood Cancer Market (Million US$), 2018 – 2022
Figure-34: Disease Indication – Forecast for Blood Cancer Market (Million US$), 2023 – 2030
Figure-35: Disease Indication – Others Market (Million US$), 2018 – 2022
Figure-36: Disease Indication – Forecast for Others Market (Million US$), 2023 – 2030
Figure-37: United States – Cancer Incidence Per Lakh of Total Population (Number), 2018 – 2022
Figure-38: United States – Forecast for Cancer Incidence Per Lakh of Total Population (Number), 2023 – 2030
Figure-39: United States – Gender Cancer Patients (Thousand), 2018 – 2022
Figure-40: United States – Forecast for Gender Cancer Patients (Thousand), 2023 – 2030
Figure-41: United States – Male Cancer Patients (Thousand), 2018 – 2022
Figure-42: United States – Forecast for Male Cancer Patients (Thousand), 2023 – 2030
Figure-43: United States – Female Cancer Patients (Thousand), 2018 – 2022
Figure-44: United States – Forecast for Female Cancer Patients (Thousand), 2023 – 2030
Figure-45: United States – Mortality Cancer Patients (Thousand), 2018 – 2022
Figure-46: United States – Forecast for Mortality Cancer Patients (Thousand), 2023 – 2030
Figure-47: United States – Cancer Pain Management Drug Price Per Capita (US$), 2018 – 2022
Figure-48: United States – Forecast for Cancer Pain Management Drug Price Per Capita (US$), 2023 – 2030
Figure-49: United States – Cancer Pain Management Market (Million US$), 2018 – 2022
Figure-50: United States – Forecast for Cancer Pain Management Market (Million US$), 2023 – 2030
Figure-51: United Kingdom – Cancer Incidence Per Lakh of Total Population (Number), 2018 – 2022
Figure-52: United Kingdom – Forecast for Cancer Incidence Per Lakh of Total Population (Number), 2023 – 2030
Figure-53: United Kingdom – Gender Cancer Patients (Thousand), 2018 – 2022
Figure-54: United Kingdom – Forecast for Gender Cancer Patients (Thousand), 2023 – 2030
Figure-55: United Kingdom – Male Cancer Patients (Thousand), 2018 – 2022
Figure-56: United Kingdom – Forecast for Male Cancer Patients (Thousand), 2023 – 2030
Figure-57: United Kingdom – Female Cancer Patients (Thousand), 2018 – 2022
Figure-58: United Kingdom – Forecast for Female Cancer Patients (Thousand), 2023 – 2030
Figure-59: United Kingdom – Mortality Cancer Patients (Thousand), 2018 – 2022
Figure-60: United Kingdom – Forecast for Mortality Cancer Patients (Thousand), 2023 – 2030
Figure-61: United Kingdom – Cancer Pain Management Drug Price Per Capita (US$), 2018 – 2022
Figure-62: United Kingdom – Forecast for Cancer Pain Management Drug Price Per Capita (US$), 2023 – 2030
Figure-63: United Kingdom – Cancer Pain Management Market (Million US$), 2018 – 2022
Figure-64: United Kingdom – Forecast for Cancer Pain Management Market (Million US$), 2023 – 2030
Figure-65: Japan – Cancer Incidence Per Lakh of Total Population (Number), 2018 – 2022
Figure-66: Japan – Forecast for Cancer Incidence Per Lakh of Total Population (Number), 2023 – 2030
Figure-67: Japan – Gender Cancer Patients (Thousand), 2018 – 2022
Figure-68: Japan – Forecast for Gender Cancer Patients (Thousand), 2023 – 2030
Figure-69: Japan – Male Cancer Patients (Thousand), 2018 – 2022
Figure-70: Japan – Forecast for Male Cancer Patients (Thousand), 2023 – 2030
Figure-71: Japan – Female Cancer Patients (Thousand), 2018 – 2022
Figure-72: Japan – Forecast for Female Cancer Patients (Thousand), 2023 – 2030
Figure-73: Japan – Mortality Cancer Patients (Thousand), 2018 – 2022
Figure-74: Japan – Forecast for Mortality Cancer Patients (Thousand), 2023 – 2030
Figure-75: Japan – Cancer Pain Management Drug Price Per Capita (US$), 2018 – 2022
Figure-76: Japan – Forecast for Cancer Pain Management Drug Price Per Capita (US$), 2023 – 2030
Figure-77: Japan – Cancer Pain Management Market (Million US$), 2018 – 2022
Figure-78: Japan – Forecast for Cancer Pain Management Market (Million US$), 2023 – 2030
Figure-79: France – Cancer Incidence Per Lakh of Total Population (Number), 2018 – 2022
Figure-80: France – Forecast for Cancer Incidence Per Lakh of Total Population (Number), 2023 – 2030
Figure-81: France – Gender Cancer Patients (Thousand), 2018 – 2022
Figure-82: France – Forecast for Gender Cancer Patients (Thousand), 2023 – 2030
Figure-83: France – Male Cancer Patients (Thousand), 2018 – 2022
Figure-84: France – Forecast for Male Cancer Patients (Thousand), 2023 – 2030
Figure-85: France – Female Cancer Patients (Thousand), 2018 – 2022
Figure-86: France – Forecast for Female Cancer Patients (Thousand), 2023 – 2030
Figure-87: France – Mortality Cancer Patients (Thousand), 2018 – 2022
Figure-88: France – Forecast for Mortality Cancer Patients (Thousand), 2023 – 2030
Figure-89: France – Cancer Pain Management Drug Price Per Capita (US$), 2018 – 2022
Figure-90: France – Forecast for Cancer Pain Management Drug Price Per Capita (US$), 2023 – 2030
Figure-91: France – Cancer Pain Management Market (Million US$), 2018 – 2022
Figure-92: France – Forecast for Cancer Pain Management Market (Million US$), 2023 – 2030
Figure-93: Germany – Cancer Incidence Per Lakh of Total Population (Number), 2018 – 2022
Figure-94: Germany – Forecast for Cancer Incidence Per Lakh of Total Population (Number), 2023 – 2030
Figure-95: Germany – Gender Cancer Patients (Thousand), 2018 – 2022
Figure-96: Germany – Forecast for Gender Cancer Patients (Thousand), 2023 – 2030
Figure-97: Germany – Male Cancer Patients (Thousand), 2018 – 2022
Figure-98: Germany – Forecast for Male Cancer Patients (Thousand), 2023 – 2030
Figure-99: Germany – Female Cancer Patients (Thousand), 2018 – 2022
Figure-100: Germany – Forecast for Female Cancer Patients (Thousand), 2023 – 2030
Figure-101: Germany – Mortality Cancer Patients (Thousand), 2018 – 2022
Figure-102: Germany – Forecast for Mortality Cancer Patients (Thousand), 2023 – 2030
Figure-103: Germany – Cancer Pain Management Drug Price Per Capita (US$), 2018 – 2022
Figure-104: Germany – Forecast for Cancer Pain Management Drug Price Per Capita (US$), 2023 – 2030
Figure-105: Germany – Cancer Pain Management Market (Million US$), 2018 – 2022
Figure-106: Germany – Forecast for Cancer Pain Management Market (Million US$), 2023 – 2030
Figure-107: Italy – Cancer Incidence Per Lakh of Total Population (Number), 2018 – 2022
Figure-108: Italy – Forecast for Cancer Incidence Per Lakh of Total Population (Number), 2023 – 2030
Figure-109: Italy – Gender Cancer Patients (Thousand), 2018 – 2022
Figure-110: Italy – Forecast for Gender Cancer Patients (Thousand), 2023 – 2030
Figure-111: Italy – Male Cancer Patients (Thousand), 2018 – 2022
Figure-112: Italy – Forecast for Male Cancer Patients (Thousand), 2023 – 2030
Figure-113: Italy – Female Cancer Patients (Thousand), 2018 – 2022
Figure-114: Italy – Forecast for Female Cancer Patients (Thousand), 2023 – 2030
Figure-115: Italy – Mortality Cancer Patients (Thousand), 2018 – 2022
Figure-116: Italy – Forecast for Mortality Cancer Patients (Thousand), 2023 – 2030
Figure-117: Italy – Cancer Pain Management Drug Price Per Capita (US$), 2018 – 2022
Figure-118: Italy – Forecast for Cancer Pain Management Drug Price Per Capita (US$), 2023 – 2030
Figure-119: Italy – Cancer Pain Management Market (Million US$), 2018 – 2022
Figure-120: Italy – Forecast for Cancer Pain Management Market (Million US$), 2023 – 2030
Figure-121: Spain – Cancer Incidence Per Lakh of Total Population (Number), 2018 – 2022
Figure-122: Spain – Forecast for Cancer Incidence Per Lakh of Total Population (Number), 2023 – 2030
Figure-123: Spain – Gender Cancer Patients (Thousand), 2018 – 2022
Figure-124: Spain – Forecast for Gender Cancer Patients (Thousand), 2023 – 2030
Figure-125: Spain – Male Cancer Patients (Thousand), 2018 – 2022
Figure-126: Spain – Forecast for Male Cancer Patients (Thousand), 2023 – 2030
Figure-127: Spain – Female Cancer Patients (Thousand), 2018 – 2022
Figure-128: Spain – Forecast for Female Cancer Patients (Thousand), 2023 – 2030
Figure-129: Spain – Mortality Cancer Patients (Thousand), 2018 – 2022
Figure-130: Spain – Forecast for Mortality Cancer Patients (Thousand), 2023 – 2030
Figure-131: Spain – Cancer Pain Management Drug Price Per Capita (US$), 2018 – 2022
Figure-132: Spain – Forecast for Cancer Pain Management Drug Price Per Capita (US$), 2023 – 2030
Figure-133: Spain – Cancer Pain Management Market (Million US$), 2018 – 2022
Figure-134: Spain – Forecast for Cancer Pain Management Market (Million US$), 2023 – 2030
Figure-135: Saudi Arabia – Cancer Incidence Per Lakh of Total Population (Number), 2018 – 2022
Figure-136: Saudi Arabia – Forecast for Cancer Incidence Per Lakh of Total Population (Number), 2023 – 2030
Figure-137: Saudi Arabia – Gender Cancer Patients (Thousand), 2018 – 2022
Figure-138: Saudi Arabia – Forecast for Gender Cancer Patients (Thousand), 2023 – 2030
Figure-139: Saudi Arabia – Male Cancer Patients (Thousand), 2018 – 2022
Figure-140: Saudi Arabia – Forecast for Male Cancer Patients (Thousand), 2023 – 2030
Figure-141: Saudi Arabia – Female Cancer Patients (Thousand), 2018 – 2022
Figure-142: Saudi Arabia – Forecast for Female Cancer Patients (Thousand), 2023 – 2030
Figure-143: Saudi Arabia – Mortality Cancer Patients (Thousand), 2018 – 2022
Figure-144: Saudi Arabia – Forecast for Mortality Cancer Patients (Thousand), 2023 – 2030
Figure-145: Saudi Arabia – Cancer Pain Management Drug Price Per Capita (US$), 2018 – 2022
Figure-146: Saudi Arabia – Forecast for Cancer Pain Management Drug Price Per Capita (US$), 2023 – 2030
Figure-147: Saudi Arabia – Cancer Pain Management Market (Million US$), 2018 – 2022
Figure-148: Saudi Arabia – Forecast for Cancer Pain Management Market (Million US$), 2023 – 2030
Figure-149: China – Cancer Incidence Per Lakh of Total Population (Number), 2018 – 2022
Figure-150: China – Forecast for Cancer Incidence Per Lakh of Total Population (Number), 2023 – 2030
Figure-151: China – Gender Cancer Patients (Thousand), 2018 – 2022
Figure-152: China – Forecast for Gender Cancer Patients (Thousand), 2023 – 2030
Figure-153: China – Male Cancer Patients (Thousand), 2018 – 2022
Figure-154: China – Forecast for Male Cancer Patients (Thousand), 2023 – 2030
Figure-155: China – Female Cancer Patients (Thousand), 2018 – 2022
Figure-156: China – Forecast for Female Cancer Patients (Thousand), 2023 – 2030
Figure-157: China – Mortality Cancer Patients (Thousand), 2018 – 2022
Figure-158: China – Forecast for Mortality Cancer Patients (Thousand), 2023 – 2030
Figure-159: China – Cancer Pain Management Drug Price Per Capita (US$), 2018 – 2022
Figure-160: China – Forecast for Cancer Pain Management Drug Price Per Capita (US$), 2023 – 2030
Figure-161: China – Cancer Pain Management Market (Million US$), 2018 – 2022
Figure-162: China – Forecast for Cancer Pain Management Market (Million US$), 2023 – 2030
Figure-163: Korea – Cancer Incidence Per Lakh of Total Population (Number), 2018 – 2022
Figure-164: Korea – Forecast for Cancer Incidence Per Lakh of Total Population (Number), 2023 – 2030
Figure-165: Korea – Gender Cancer Patients (Thousand), 2018 – 2022
Figure-166: Korea – Forecast for Gender Cancer Patients (Thousand), 2023 – 2030
Figure-167: Korea – Male Cancer Patients (Thousand), 2018 – 2022
Figure-168: Korea – Forecast for Male Cancer Patients (Thousand), 2023 – 2030
Figure-169: Korea – Female Cancer Patients (Thousand), 2018 – 2022
Figure-170: Korea – Forecast for Female Cancer Patients (Thousand), 2023 – 2030
Figure-171: Korea – Mortality Cancer Patients (Thousand), 2018 – 2022
Figure-172: Korea – Forecast for Mortality Cancer Patients (Thousand), 2023 – 2030
Figure-173: Korea – Cancer Pain Management Drug Price Per Capita (US$), 2018 – 2022
Figure-174: Korea – Forecast for Cancer Pain Management Drug Price Per Capita (US$), 2023 – 2030
Figure-175: Korea – Cancer Pain Management Market (Million US$), 2018 – 2022
Figure-176: Korea – Forecast for Cancer Pain Management Market (Million US$), 2023 – 2030
Figure-177: Daiichi Sankyo Co., Ltd. – Global Revenue (Billion US$), 2018 – 2022
Figure-178: Daiichi Sankyo Co., Ltd. – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-179: Hisamitsu Pharmaceutical Co., Inc. – Global Revenue (Billion US$), 2018 – 2022
Figure-180: Hisamitsu Pharmaceutical Co., Inc. – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-181: Orexo AB – Global Revenue (Billion US$), 2018 – 2022
Figure-182: Orexo AB – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-183: Pfizer Inc – Global Revenue (Billion US$), 2018 – 2022
Figure-184: Pfizer Inc – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-185: Teva Pharmaceutical Industries Limited – Global Revenue (Billion US$), 2018 – 2022
Figure-186: Teva Pharmaceutical Industries Limited – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-187: Sanofi – Global Revenue (Billion US$), 2018 – 2022
Figure-188: Sanofi – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-189: Johnson & Johnson – Global Revenue (Billion US$), 2018 – 2022
Figure-190: Johnson & Johnson – Forecast for Global Revenue (Billion US$), 2023 – 2030
Figure-191: Eli Lilly – Global Revenue (Billion US$), 2018 – 2022
Figure-192: Eli Lilly – Forecast for Global Revenue (Billion US$), 2023 – 2030

List of Tables

Table-01: Global – Cancer Patients - 10 MM Population (Number), 2018 – 2022
Table-02: Global – Forecast for Cancer Patients - 10 MM Population (Number), 2023 – 2030
Table-03: Global – Cancer Patients by Type, 2020 - 10 MM Population (Number), 2018 – 2022
Table-04: Global – Forecast for Cancer Patients by Type, 2020 - 10 MM Population (Number), 2023 – 2030
Table-05: Global – Cancer Patients by Male - 10 MM Population (Number), 2018 – 2022
Table-06: Global – Forecast for Cancer Patients by Male - 10 MM Population (Number), 2023 – 2030
Table-07: Global – Cancer Patients by Female - 10 MM Population (Number), 2018 – 2022
Table-08: Global – Forecast for Cancer Patients by Female - 10 MM Population (Number), 2023 – 2030
Table-09: Global – Cancer Patients by Mortality Rate – 10 MM Population (Number), 2018 – 2022
Table-10: Global – Forecast for Cancer Patients by Mortality Rate – 10 MM Population (Number), 2023 – 2030
Table-11: Global – Cancer Pain Management Market Share by Treatment (Percent), 2018 – 2022
Table-12: Global – Forecast for Cancer Pain Management Market Share by Treatment (Percent), 2022 – 2030
Table-13: Global – Cancer Pain Management Market Share by Drug Type (Percent), 2018 – 2022
Table-14: Global – Forecast for Cancer Pain Management Market Share by Drug Type (Percent), 2022 – 2030
Table-15: Global – Cancer Pain Management Market Share by Disease Indication (Percent), 2018 – 2022
Table-16: Global – Forecast for Cancer Pain Management Market Share by Disease Indication (Percent), 2022 – 2030
Table-17: Global – Cancer Pain Management Market Share by Country (Percent), 2018 – 2022
Table-18: Global – Forecast for Cancer Pain Management Market Share by Country (Percent), 2022 – 2030
Table-19: United States – Cancer Patients by Type, 2020
Table-20: Korea – Cancer Patients by Type, 2020
Table-21: United Kingdom – Cancer Patients by Type, 2020
Table-22: Japan – Cancer Patients by Type, 2020
Table-23: France – Cancer Patients by Type, 2020
Table-24: Germany – Cancer Patients by Type, 2020
Table-25: Italy – Cancer Patients by Type, 2020
Table-26: Spain – Cancer Patients by Type, 2020
Table-27: Saudi Arabia – Cancer Patients by Type, 2020
Table-28: China – Cancer Patients by Type, 2020